Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies

Published:2016-07 Issue:7 Volume:4 Page:549-556
ISSN:2213-2600
Container-title:The Lancet Respiratory Medicine
language:en
Short-container-title:The Lancet Respiratory Medicine

Author:

Ortega Hector G,Yancey Steven W,Mayer Bhabita,Gunsoy Necdet B,Keene Oliver N,Bleecker Eugene R,Brightling Christopher E,Pavord Ian D

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference27 articles.

1. Severe asthma: from characteristics to phenotypes to endotypes;Wenzel;Clin Exp Allergy,2012

2. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma;Chung;Eur Respir J,2014

3. Blood eosinophil counts predict treatment response in patients with severe eosinophilic asthma;Ortega;J Allergy Clin Immunol,2015

4. Targeting eosinophils in allergy, inflammation and beyond;Fulkerson;Nat Rev Drug Discov,2013

5. Anti-IL5 therapy for asthma and beyond;Mukherjee;World Allergy Organ J,2014

Cited by 449 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The new biologic drugs: Which children with asthma should get what?;Pediatric Pulmonology;2024-09-13

2. Exploring Definitions and Predictors of Response to Biologics for Severe Asthma;The Journal of Allergy and Clinical Immunology: In Practice;2024-09

3. Biologics in Asthma;Immunology and Allergy Clinics of North America;2024-09

4. Therapeutic relevance of eosinophilic inflammation and airway viral interactions in severe asthma;Allergy;2024-08

5. Treating severe paediatric asthma with mepolizumab or omalizumab: a protocol for the TREAT randomised non-inferiority trial;BMJ Open;2024-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3